Sort
23,748 grants matching “melanoma”
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges
$432,394Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · NS
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges
$432,394Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · NS
Role of PTPRT in colon cancer progression and metastasis
$432,159Zhenghe Wang · Case Western Reserve University · R01 · FY2023 · CA
Targeted Chemoprevention for Melanoma
$432,123Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2011 · CA
RasGRP3 and Protein Kinase D as therapeutic targets for Uveal Melanoma
$432,122Xu Chen · University Of California, San Francisco · R01 · FY2024 · CA
Molecular Epidemiology of Non-Melanoma Skin Cancer
$431,864Harvard University (Sch Of Public Hlth) · R01 · FY2005 · CA
Mechanisms linking hemostatic factors and malignancy
$431,691Children'S Hospital Med Ctr (Cincinnati) · R01 · FY2004 · HL
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
$431,631Pan Zheng · University Of Maryland Baltimore · R01 · FY2018 · CA
Targeting Gq pathway in uveal melanoma
$431,571Xu Chen · University Of California, San Francisco · R01 · FY2024 · CA
Biomaterials for Targeted Modulation of Conventional Type 1 Dendritic Cells
$431,451Hua Wang · University Of Illinois At Urbana-Champaign · R01 · FY2024 · CA
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$431,440Melody A Swartz · University Of Chicago · R01 · FY2023 · CA
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$431,440Melody A Swartz · University Of Chicago · R01 · FY2022 · CA
Development of Methods for Cancer Biomarker Detection
$431,348Wistar Institute · R33 · FY2002 · CA
Immune Checkpoints and HPV-associated Head and Neck Cancers
$431,300Sara Isabel Pai · Massachusetts General Hospital · R01 · FY2015 · DE
Immune Checkpoints and HPV-associated Head and Neck Cancers
$431,300Sara Isabel Pai · Massachusetts General Hospital · R01 · FY2016 · DE
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia
$431,271Kevin M Shannon · Indiana University Indianapolis · U54 · FY2015 · CA
Northern New Jersey Community Clinical Oncology Program
$431,140Hackensack University Medical Center · U10 · FY2002 · CA
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles
$431,104Michelle S Bradbury · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Gene Function, Expression and Regulation in Zebrafish
$431,031Benjamin Feldman · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIC · FY2015 · HD
Restoration of Tumor Suppression Activity in Malignant Melanoma
$431,029David Joseph Weber · University Of Maryland Baltimore · R01 · FY2013 · CA
Eukaryotic transcriptome engineering via sequence-specific regulation of endogenous RNA
$430,976Patrick Hsu · University Of California Berkeley · DP5 · FY2018 · OD
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
$430,781Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
$430,742Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
The filopodial tip complex in adhesion, migration, and signaling
$430,735Richard E Cheney · Univ Of North Carolina Chapel Hill · R01 · FY2020 · GM
The filopodial tip complex in adhesion, migration, and signaling
$430,735Richard E Cheney · Univ Of North Carolina Chapel Hill · R01 · FY2021 · GM